Dr. Amanullah Khan, MD, PHD
What this data tells you about Dr. Khan
Dr. Amanullah Khan is a hematology & oncology in McKinney, TX, with 20 years in practice. Based on federal Medicare data, Dr. Khan performed 6,367 Medicare services across 1,201 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $2,272 from 38 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,800 | $18 | $43 |
| Flow cytometry, additional marker | 915 | $18 | $47 |
| Complete blood count (CBC) with differential | 727 | $8 | $12 |
| Office visit, established patient (30-39 min) | 527 | $82 | $319 |
| Blood draw (venipuncture) | 463 | $3 | $3 |
| Infusion, normal saline solution, 250 cc | 434 | $1 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 225 | $21 | $90 |
| Drug injection, under skin or into muscle | 165 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 144 | $46 | $205 |
| Injection of additional new drug or substance into vein | 122 | $11 | $47 |
| Injection, triptorelin pamoate, 3.75 mg | 102 | $287 | $1,500 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 92 | $1 | $10 |
| Unclassified drugs | 86 | $0 | $2 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 75 | $3 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 73 | $16 | $63 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $21 | $92 |
| Administration of chemotherapy into vein, 1 hour or less | 71 | $89 | $404 |
| Contrast dye for imaging (iodine-based) | 49 | $0 | $1 |
| Flow cytometry technique for dna or cell analysis, first marker | 35 | $51 | $127 |
| Ct scan of chest with contrast | 32 | $57 | $518 |
| Office visit, established patient, complex (40-54 min) | 30 | $116 | $285 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 29 | $116 | $450 |
| CT scan of chest, without contrast | 27 | $62 | $318 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 27 | $1,197 | $7,881 |
| CT scan of abdomen and pelvis with contrast | 23 | $181 | $1,084 |
| Office visit, established patient (20-29 min) | 22 | $59 | $145 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khan is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with denosumab injection (prolia/xgeva)?
Does Dr. Khan receive payments from pharmaceutical companies?
How do Dr. Khan's costs compare to other hematology & oncologys in McKinney?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology